The pathogenesis of bladder infections involves a complex interplay between bacteria and the host urinary tract. Adherence of uropathogenic bacteria, primarily Escherichia coli, to the uroepithelial cells is a crucial step. Fimbriae, specialized appendages on the bacterial surface, facilitate attachment to the bladder lining. Once attached, bacteria can invade and multiply, triggering an inflammatory response. The host immune system responds by recruiting immune cells, causing the characteristic symptoms of bladder infection such as inflammation and pain. Treatment of bladder infections typically involves antibiotics, with nitrofurantoin, trimethoprim-sulfamethoxazole, and fluoroquinolones being common choices. However, increasing antibiotic resistance is a concern, necessitating careful consideration of appropriate antimicrobial agents. For recurrent infections, prophylactic antibiotic therapy or post-coital prophylaxis may be recommended. Non-antibiotic approaches, such as the use of probiotics or vaccination strategies, are also under investigation to provide alternative or adjunctive therapies. Understanding the intricate details of the pathogenesis of bladder infections is crucial for developing targeted interventions that can effectively manage acute infections and prevent recurrence while minimizing the risk of antibiotic resistance.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain